Alloy Therapeutics snags $75m Series C

Alloy Therapeutics, a biotechnology ecosystem company, has secured $75 million in Series C financing.

2 April 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles